Research Progress on Treating Spinal Cord Injury by Modulating the Phenotype of Microglia

Qinghe Yu1, Ziming Cai1, Xiaofeng Liu1

  • 1Department of Spine Surgery, Shenzhen Pingle Orthopedic Hospital, Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, 518118 Shenzhen, Guangdong, China.

PubMed

Insights

Modulating microglia polarization is key for spinal cord injury (SCI) treatment. Shifting immune cells from inflammatory (M1) to repair (M2) phenotypes offers a promising therapeutic strategy for central nervous system recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Spinal cord injury (SCI) is a severe neurological disorder lacking effective treatments.
  • Microglia, the central nervous system's immune cells, are critical in SCI pathogenesis and recovery.
  • Microglia dynamically polarize into M1 (pro-inflammatory) and M2 (anti-inflammatory/repair) phenotypes.

Purpose of the Study:

  • To review the role of microglial polarization in SCI.
  • To explore strategies for modulating microglial phenotypes for SCI treatment.

Main Methods:

  • Comprehensive literature review on microglial polarization in SCI.
  • Analysis of M1 and M2 phenotypes' functions and regulation.

Main Results:

  • M1 phenotype exacerbates inflammation and damage post-SCI.
  • M2 phenotype promotes tissue repair and resolution of inflammation.
  • Targeting microglial polarization is a key therapeutic avenue.

Conclusions:

  • Modulating microglial polarization from M1 to M2 is a promising strategy for SCI treatment.
  • Further research into targeted interventions is warranted to harness M2-mediated repair mechanisms.

Related Concept Videos